Microfluidics for diagnosis and treatment of cardiovascular disease

被引:11
|
作者
Ma, Yonggeng [1 ]
Liu, Chenbin [3 ]
Cao, Siyu [1 ]
Chen, Tianshu [2 ]
Chen, Guifang [1 ]
机构
[1] Shanghai Univ, Sch Life Sci, Shanghai 200444, Peoples R China
[2] Shanghai Jiao Tong Univ, Dept Clin Lab Med, Shanghai Childrens Med Ctr, Sch Med, Shanghai 200127, Peoples R China
[3] Tongji Univ, Shanghai Peoples Hosp 10, Dept Clin Lab Med, Shanghai 200072, Peoples R China
基金
中国国家自然科学基金;
关键词
CARDIAC TROPONIN-I; MYOCARDIAL-INFARCTION; CHOLESTEROL; BIOMARKERS; MYELOPEROXIDASE; INDIVIDUALS; MORTALITY; MARKERS; POINT; RISK;
D O I
10.1039/d2tb02287g
中图分类号
TB3 [工程材料学]; R318.08 [生物材料学];
学科分类号
0805 ; 080501 ; 080502 ;
摘要
Cardiovascular disease (CVD), a type of circulatory system disease related to the lesions of the cardiovascular system, has become one of the main diseases that endanger human health. Currently, the clinical diagnosis of most CVDs relies on a combination of imaging technology and blood biochemical test. However, the existing technologies for diagnosis of CVDs still have limitations in terms of specificity, detection range, and cost. In order to break through the current bottleneck, microfluidic with the advantages of low cost, simple instruments and easy integration, has been developed to play an important role in the early prevention, diagnosis and treatment of CVDs. Here, we have reviewed the recent various applications of microfluidic in the clinical diagnosis and treatment of CVDs, including microfluidic devices for detecting CVD markers, the cardiovascular models based on microfluidic, and the microfluidic used for CVDs drug screening and delivery. In addition, we have briefly looked forward to the prospects and challenges of microfluidics in diagnosis and treatment of CVDs.
引用
收藏
页码:546 / 559
页数:14
相关论文
共 50 条
  • [1] Diagnosis and treatment of the cardiovascular consequences of Fabry disease
    Baig, S.
    Vijapurapu, R.
    Alharbi, F.
    Nordin, S.
    Kozor, R.
    Moon, J.
    Bembi, B.
    Geberhiwot, T.
    Steeds, R. P.
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2019, 112 (01) : 3 - 9
  • [2] Current Challenges in Diagnosis and Treatment of Cardiovascular Disease
    Samanidis, George
    JOURNAL OF PERSONALIZED MEDICINE, 2024, 14 (08):
  • [3] Liposome technology for cardiovascular disease treatment and diagnosis
    Bowey, Kristen
    Tanguay, Jean-Francois
    Tabrizian, Maryam
    EXPERT OPINION ON DRUG DELIVERY, 2012, 9 (02) : 249 - 265
  • [4] PROTEOMIC HORIZONS IN THE DIAGNOSIS AND TREATMENT OF CARDIOVASCULAR DISEASE
    Lopez Farre, Antonio
    Gonzalez Armengol, Juan
    Mateos-Caceres, Petra J.
    Macaya, Carlos
    CLINICA E INVESTIGACION EN ARTERIOSCLEROSIS, 2008, 20 (04): : 164 - 172
  • [5] Application of microRNAs in diagnosis and treatment of cardiovascular disease
    Wronska, A.
    Kurkowska-Jastrzebska, I.
    Santulli, G.
    ACTA PHYSIOLOGICA, 2015, 213 (01) : 60 - 83
  • [6] Updates in Cardiovascular Disease Prevention, Diagnosis, and Treatment in Women
    Jones, Sarah
    McNeil, Melissa
    Koczo, Agnes
    MEDICAL CLINICS OF NORTH AMERICA, 2023, 107 (02) : 285 - 298
  • [8] Cardiovascular disease in older women: a challenge in diagnosis and treatment
    Mankad, Rekha
    Best, Patricia J. M.
    WOMENS HEALTH, 2008, 4 (05) : 449 - 464
  • [9] Inflammation in atherosclerotic cardiovascular disease: From diagnosis to treatment
    Arnold, Natalie
    Koenig, Wolfgang
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2025,
  • [10] Organic Nanoparticles in Progressing Cardiovascular Disease Treatment and Diagnosis
    Udriste, Alexandru Scafa
    Burdusel, Alexandra Cristina
    Niculescu, Adelina-Gabriela
    Radulescu, Marius
    Balaure, Paul Catalin
    Grumezescu, Alexandru Mihai
    POLYMERS, 2024, 16 (10)